ChangeGradients: Promoting Adolescent Health Behavior Change
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Sep 30, 2019
Trial Information
Current as of June 02, 2025
Recruiting
Keywords
ClinConnect Summary
The ChangeGradients trial is studying a new way to help teenagers change their health behaviors, especially related to alcohol use. The goal is to create an interactive program that encourages adolescents to make better choices about drinking. By using advanced technology that personalizes the experience for each individual, the program aims to help young people understand the risks of alcohol and motivate them to adopt healthier habits.
To participate in this trial, adolescents aged 15 to 17 who currently drink alcohol and are visiting specific UCSF pediatric clinics may be eligible. Participants will engage with a unique digital tool that provides personalized stories and feedback about their choices, making the learning experience engaging and relevant. This trial is not only looking to improve the health of the participants but also hopes to find effective ways to integrate these innovative tools into regular healthcare for better support and outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescents between the ages of 15 and 17 years of age
- • Report current alcohol use
- • Presenting for a well-visit at UCSF Pediatric primary care clinics (the Mt. Zion Pediatric Primary Care Practices at UCSF and The Adolescent/Young Adult Clinic at UCSF)
- Exclusion Criteria:
- • Non-English speakers
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
San Francisco, California, United States
Patients applied
Trial Officials
Elizabeth Ozer, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials